Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma.

Zhang Y, Sun Y, Ma J.

Cancer Commun (Lond). 2019 Jun 25;39(1):39. doi: 10.1186/s40880-019-0385-5.

2.

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.

Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Tang LL, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Chua MLK, Xie FY, Sun Y, Ma J.

N Engl J Med. 2019 May 31. doi: 10.1056/NEJMoa1905287. [Epub ahead of print]

PMID:
31150573
3.
4.

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.

Fangzheng W, Quanquan S, Chuner J, Lei W, Fengqin Y, Zhimin Y, Tongxin L, Min X, Peng W, Haitao J, Aizawa R, Sakamoto M, Yuezhen W, Zhenfu F.

Oncotarget. 2017 May 27;8(57):96798-96808. doi: 10.18632/oncotarget.18245. eCollection 2017 Nov 14.

6.
7.

Is Gemcitabine and Cisplatin Induction Chemotherapy Superior in Locoregionally Advanced Nasopharyngeal Carcinoma?

Zheng W, Qiu S, Huang L, Pan J.

Pak J Med Sci. 2015 Jul-Aug;31(4):781-6. doi: 10.12669/pjms.314.7374.

8.

Analysis on clinical characteristics and influencing factors of patients with locoregionally advanced nasopharyngeal carcinoma.

Zheng W, Xu YJ, Qiu SF, Zong JF, Huang LL, Huang CB, Lin SJ, Pan JJ.

Asian Pac J Cancer Prev. 2015;16(10):4393-9.

Supplemental Content

Loading ...
Support Center